Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cormedix Inc. (CRMD) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cormedix Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1410098.
Total stock buying since 2010: $3,297,485.
Total stock sales since 2010: $3,182,382.
Total stock option exercises since 2010: $2,259,815.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 59,170 | $199,994 |
| 2024 | 15,061 | $65,703 | 140,027 | $1,565,641 | 152,527 | $638,523 |
| 2023 | 23,000 | $88,608 | 0 | $0 | 15,000 | $33,750 |
| 2022 | 39,700 | $147,524 | 0 | $0 | 0 | $0 |
| 2021 | 14,000 | $69,970 | 8,000 | $55,392 | 0 | $0 |
| 2020 | 139,520 | $595,807 | 0 | $0 | 0 | $0 |
| 2019 | 140,316 | $581,779 | 0 | $0 | 0 | $0 |
| 2018 | 520,000 | $708,970 | 0 | $0 | 1,088,386 | $1,061,600 |
| 2017 | 1,402,671 | $631,402 | 10,000 | $20,000 | 28,028 | $6,800 |
| 2016 | 78,703 | $148,952 | 296,106 | $787,197 | 500,000 | $299,049 |
| 2015 | 29,728 | $109,115 | 115,797 | $749,087 | 70,000 | $20,099 |
| 2014 | 59,484 | $100,088 | 0 | $0 | 0 | $0 |
| 2013 | 18,000 | $13,950 | 125 | $115 | 0 | $0 |
| 2012 | 0 | $0 | 11,000 | $4,950 | 0 | $0 |
| 2011 | 56,500 | $18,464 | 0 | $0 | 0 | $0 |
| 2010 | 176,800 | $17,153 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-04 | 0 | $0 | 0 | $0 | 59,170 | $199,994 |
| 2024-12 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2024-11 | 0 | $0 | 140,027 | $1,565,641 | 140,027 | $638,523 |
| 2024-10 | 1,500 | $14,985 | 0 | $0 | 0 | $0 |
| 2024-03 | 13,561 | $50,718 | 0 | $0 | 0 | $0 |
| 2023-12 | 6,000 | $20,250 | 0 | $0 | 0 | $0 |
| 2023-11 | 1,000 | $4,000 | 0 | $0 | 15,000 | $33,750 |
| 2023-09 | 10,000 | $37,100 | 0 | $0 | 0 | $0 |
| 2023-05 | 6,000 | $27,258 | 0 | $0 | 0 | $0 |
| 2022-11 | 20,000 | $76,400 | 0 | $0 | 0 | $0 |
| 2022-08 | 4,700 | $18,424 | 0 | $0 | 0 | $0 |
| 2022-05 | 15,000 | $52,700 | 0 | $0 | 0 | $0 |
| 2021-12 | 3,000 | $13,500 | 0 | $0 | 0 | $0 |
| 2021-11 | 11,000 | $56,470 | 0 | $0 | 0 | $0 |
| 2021-05 | 0 | $0 | 8,000 | $55,392 | 0 | $0 |
| 2020-09 | 22,165 | $92,843 | 0 | $0 | 0 | $0 |
| 2020-08 | 100,605 | $445,417 | 0 | $0 | 0 | $0 |
| 2020-05 | 10,000 | $38,500 | 0 | $0 | 0 | $0 |
| 2020-03 | 6,750 | $19,047 | 0 | $0 | 0 | $0 |
| 2019-12 | 18,425 | $121,965 | 0 | $0 | 0 | $0 |
| 2019-09 | 11,000 | $74,679 | 0 | $0 | 0 | $0 |
| 2019-08 | 15,147 | $123,243 | 0 | $0 | 0 | $0 |
| 2019-05 | 11,144 | $75,110 | 0 | $0 | 0 | $0 |
| 2019-03 | 84,600 | $186,782 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | Todisco Joseph (Chief Executive Officer) | Option Ex | 59,170 | 3.38 | 199,994 |
| 2024-12-12 | Zelnick Kaufman Beth (Chief Legal Officer) | Option Ex | 12,500 | .00 | 0 |
| 2024-11-14 | Hurlburt Elizabeth (EVP) | Sale | 140,027 | 11.18 | 1,565,641 |
| 2024-11-14 | Hurlburt Elizabeth (EVP) | Option Ex | 140,027 | 4.56 | 638,523 |
| 2024-10-31 | Mistry Erin (EVP, Chief Commercial Officer) | Buy | 1,500 | 9.99 | 14,985 |
| 2024-03-13 | Todisco Joseph (Chief Executive Officer) | Buy | 13,561 | 3.74 | 50,718 |
| 2023-12-15 | Dunton Alan W | Buy | 3,000 | 3.30 | 9,900 |
| 2023-12-14 | Dunton Alan W | Buy | 3,000 | 3.45 | 10,350 |
| 2023-11-17 | Mistry Erin (Chief Commercial Officer) | Buy | 1,000 | 4.00 | 4,000 |
| 2023-11-16 | Lefkowitz Steven W | Option Ex | 15,000 | 2.25 | 33,750 |
| 2023-09-08 | Todisco Joseph (Chief Executive Officer) | Buy | 10,000 | 3.71 | 37,100 |
| 2023-05-18 | Kaplan Myron | Buy | 6,000 | 4.54 | 27,258 |
| 2022-11-15 | Todisco Joseph (Chief Executive Officer) | Buy | 20,000 | 3.82 | 76,400 |
| 2022-08-24 | Todisco Joseph (Chief Executive Officer) | Buy | 4,700 | 3.92 | 18,424 |
| 2022-05-17 | Kaplan Myron | Buy | 5,000 | 3.78 | 18,900 |
| 2022-05-16 | Todisco Joseph (Chief Executive Officer) | Buy | 10,000 | 3.38 | 33,800 |
| 2021-12-06 | David Matthew T (Interim CEO and CFO) | Buy | 2,000 | 4.50 | 9,000 |
| 2021-11-17 | David Matthew T (Interim CEO and CFO) | Buy | 1,000 | 5.07 | 5,070 |
| 2021-11-16 | Kaplan Myron | Buy | 10,000 | 5.14 | 51,400 |
| 2021-05-21 | Masson-hurlburt Elizabeth (EVP, Head of Clinical Ops) | Sale | 8,000 | 6.92 | 55,392 |
| 2020-09-04 | Lefkowitz Steven W | Buy | 5,715 | 3.99 | 22,802 |
| 2020-09-03 | David Matthew T (Chief Financial Officer) | Buy | 1,150 | 4.07 | 4,680 |
| 2020-09-02 | Kaplan Myron | Buy | 15,300 | 4.27 | 65,361 |
| 2020-08-19 | Khan Mehmood | Buy | 17,837 | 4.90 | 87,472 |
| 2020-08-18 | Khan Mehmood | Buy | 27,913 | 4.69 | 130,967 |
| 2020-08-14 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Buy | 27,500 | 4.21 | 115,912 |
| 2020-08-13 | Mounts Phoebe (General Counsel) | Buy | 2,525 | 4.03 | 10,175 |
| 2020-08-13 | Baluch Khoso (Chief Executive Officer) | Buy | 4,830 | 4.14 | 19,986 |
| 2020-08-13 | Kaplan Myron | Buy | 15,000 | 4.08 | 61,155 |
| 2020-08-12 | Dunton Alan W | Buy | 5,000 | 3.95 | 19,750 |
| 2020-05-15 | Kaplan Myron | Buy | 10,000 | 3.85 | 38,500 |
| 2020-03-18 | Mounts Phoebe (General Counsel) | Buy | 3,250 | 3.05 | 9,912 |
| 2020-03-18 | Baluch Khoso (Chief Executive Officer) | Buy | 3,500 | 2.61 | 9,135 |
| 2019-12-30 | Mounts Phoebe (General Counsel) | Buy | 1,425 | 7.04 | 10,037 |
| 2019-12-13 | Khan Mehmood | Buy | 17,000 | 6.58 | 111,928 |
| 2019-09-30 | Kaplan Myron | Buy | 5,000 | 6.81 | 34,050 |
| 2019-09-30 | Cook Robert W. (Chief Financial Officer) | Buy | 1,000 | 6.88 | 6,879 |
| 2019-09-27 | Lefkowitz Steven W | Buy | 5,000 | 6.75 | 33,750 |
| 2019-08-16 | Kaplan Myron | Buy | 6,000 | 8.06 | 48,360 |
| 2019-08-16 | Dillione Janet | Buy | 6,147 | 8.19 | 50,343 |
| 2019-08-16 | Cook Robert W. (Chief Financial Officer) | Buy | 2,000 | 8.18 | 16,360 |
| 2019-05-15 | Dillione Janet | Buy | 11,144 | 6.74 | 75,110 |
| 2019-03-29 | Cook Robert W. (Chief Financial Officer) | Buy | 100 | 9.35 | 935 |
| 2019-03-26 | Baluch Khoso (Chief Executive Officer) | Buy | 2,500 | 7.55 | 18,875 |
| 2019-03-26 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Buy | 5,000 | 7.73 | 38,650 |
| 2019-03-25 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Buy | 15,000 | 1.69 | 25,350 |
| 2019-03-22 | Kaplan Myron | Buy | 20,000 | 1.65 | 33,000 |
| 2019-03-18 | Dillione Janet | Buy | 42,000 | 1.67 | 69,972 |
| 2018-12-31 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Option Ex | 18,029 | .00 | 0 |
| 2018-12-20 | Khan Mehmood | Buy | 100,000 | 1.24 | 124,400 |
| 2018-12-20 | Lefkowitz Steven W | Buy | 20,000 | 1.18 | 23,500 |
| 2018-12-14 | Kaplan Myron | Buy | 50,000 | 1.47 | 73,300 |
| 2018-12-05 | Masson Elizabeth (EVP, Head of Clinical Ops.) | Option Ex | 40,000 | .29 | 11,600 |
| 2018-11-29 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Buy | 250,000 | 1.45 | 363,250 |
| 2018-11-27 | Baluch Khoso (Chief Executive Officer) | Buy | 21,500 | 1.21 | 26,015 |
| 2018-11-27 | Cook Robert W. (Chief Financial Officer) | Buy | 25,000 | 1.17 | 29,225 |
| 2018-11-26 | Baluch Khoso (Chief Executive Officer) | Buy | 3,500 | 1.28 | 4,480 |
| 2018-11-23 | Kaplan Myron | Buy | 50,000 | 1.30 | 64,800 |
| 2018-11-06 | Kaplan Myron | Option Ex | 5,000 | .00 | 0 |
| 2018-10-12 | Gelbfish Gary A. | Option Ex | 1,000,000 | 1.05 | 1,050,000 |
| 2018-02-21 | Kaplan Myron | Option Ex | 10,000 | .00 | 0 |
| 2018-02-21 | Dillione Janet | Option Ex | 15,357 | .00 | 0 |
| 2017-12-31 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Option Ex | 18,028 | .00 | 0 |
| 2017-12-12 | Baluch Khoso (Chief Executive Officer) | Buy | 104,166 | .48 | 49,999 |
| 2017-12-12 | Kaplan Myron | Buy | 104,166 | .48 | 49,999 |
| 2017-12-12 | Khan Mehmood | Buy | 52,083 | .48 | 24,999 |
| 2017-12-12 | Dillione Janet | Buy | 52,083 | .48 | 24,999 |
| 2017-12-12 | Gelbfish Gary A. | Buy | 52,083 | .48 | 24,999 |
| 2017-12-12 | Lefkowitz Steven W | Buy | 135,416 | .48 | 64,999 |
| 2017-12-12 | Armstrong Jr. John L. (Exec VP of Tech Operations) | Buy | 20,833 | .48 | 9,999 |
| 2017-12-12 | Cook Robert W. (Chief Financial Officer) | Buy | 52,083 | .48 | 24,999 |
| 2017-08-18 | Baluch Khoso (Chief Executive Officer) | Buy | 36,207 | .41 | 15,025 |
| 2017-08-18 | Khan Mehmood | Buy | 50,000 | .42 | 21,000 |
| 2017-08-17 | Kaplan Myron | Buy | 80,000 | .40 | 31,840 |
| 2017-08-17 | Khan Mehmood | Buy | 150,000 | .41 | 61,499 |
| 2017-08-16 | Khan Mehmood | Buy | 100,000 | .39 | 39,000 |
| 2017-08-15 | Khan Mehmood | Buy | 50,000 | .37 | 18,500 |
| 2017-08-14 | Kaplan Myron | Buy | 50,000 | .35 | 17,400 |
| 2017-08-14 | Khan Mehmood | Buy | 50,000 | .35 | 17,500 |
| 2017-05-30 | Tellez Cora M (Director) | Buy | 7,550 | .41 | 3,133 |
| 2017-05-17 | Baluch Khoso (Chief Executive Officer) | Buy | 75,000 | .47 | 35,625 |
| 2017-05-16 | Tellez Cora M (Director) | Buy | 50,000 | .48 | 24,000 |
| 2017-05-15 | Kaplan Myron (Director) | Buy | 30,000 | .49 | 14,820 |
| 2017-05-15 | Markvicka Taunia (Director) | Buy | 14,500 | .51 | 7,395 |
| 2017-05-15 | Dillione Janet (Director) | Buy | 21,231 | .47 | 10,084 |
| 2017-05-15 | Cook Robert W. (Chief Financial Officer) | Buy | 50,000 | .50 | 24,950 |
| 2017-05-15 | George Michael W (Director) | Buy | 10,000 | .50 | 4,990 |
| 2017-03-30 | Tellez Cora M (Director) | Buy | 1,950 | 1.66 | 3,237 |
| 2017-02-28 | Tellez Cora M (Director) | Buy | 1,540 | 2.10 | 3,230 |
| 2017-02-07 | Pfaffle Antony (Chief Scientific Officer) | Sale | 10,000 | 2.00 | 20,000 |
| 2017-02-07 | Pfaffle Antony (Chief Scientific Officer) | Option Ex | 10,000 | .68 | 6,800 |
| 2017-01-30 | Tellez Cora M (Director) | Buy | 1,780 | 1.79 | 3,182 |
| 2016-12-30 | Tellez Cora M (Director) | Buy | 1,990 | 1.58 | 3,144 |
| 2016-12-09 | Baluch Khoso (Chief Executive Officer) | Buy | 10,000 | 1.77 | 17,700 |
| 2016-11-30 | Tellez Cora M (Director) | Buy | 1,800 | 1.80 | 3,240 |
| 2016-10-31 | Tellez Cora M (Director) | Buy | 1,475 | 2.15 | 3,171 |
| 2016-10-21 | Pfaffle Antony (Chief Scientific Officer) | Sale | 20,000 | 2.23 | 44,600 |
| 2016-10-21 | Pfaffle Antony (Chief Scientific Officer) | Option Ex | 20,000 | .68 | 13,600 |
| 2016-08-25 | Markvicka Taunia (Director) | Buy | 18,600 | 1.65 | 30,690 |
| 2016-08-19 | Kaplan Myron (Director) | Buy | 20,000 | 1.73 | 34,500 |
| 2016-08-19 | Tellez Cora M (Director) | Buy | 12,500 | 1.73 | 21,587 |
| 2016-08-09 | Milby Randy (Chief Executive Officer) | Option Ex | 150,000 | .48 | 72,750 |
| 2016-06-21 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 19,657 | 2.15 | 42,262 |
| 2016-06-21 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 19,657 | .68 | 13,366 |
| 2016-06-20 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 10,000 | 2.16 | 21,570 |
| 2016-06-20 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 10,000 | .68 | 6,800 |
| 2016-06-15 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 4,900 | 2.21 | 10,819 |
| 2016-06-15 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 4,900 | .68 | 3,332 |
| 2016-06-13 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 443 | 2.20 | 974 |
| 2016-06-13 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 443 | .68 | 301 |
| 2016-06-10 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 5,000 | 2.28 | 11,405 |
| 2016-06-10 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 5,000 | .68 | 3,400 |
| 2016-06-09 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 10,000 | 2.38 | 23,790 |
| 2016-06-09 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 10,000 | .68 | 6,800 |
| 2016-06-08 | Dillione Janet (Director) | Buy | 3,738 | 2.67 | 9,980 |
| 2016-06-03 | Duffy Matthew (Director) | Sale | 46,106 | 2.73 | 126,007 |
| 2016-06-01 | Lefkowitz Steven W (Director) | Option Ex | 100,000 | .68 | 68,000 |
| 2016-05-31 | Lefkowitz Steven W (Director) | Sale | 42,200 | 2.85 | 120,438 |
| 2016-05-27 | Lefkowitz Steven W (Director) | Sale | 7,800 | 3.04 | 23,727 |
| 2016-05-25 | Tellez Cora M (Director) | Buy | 8,600 | 2.90 | 24,940 |
| 2016-05-24 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 12,700 | 2.74 | 34,798 |
| 2016-05-24 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 12,700 | .68 | 8,636 |
| 2016-05-23 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 5,000 | 2.87 | 14,345 |
| 2016-05-23 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 5,000 | .68 | 3,400 |
| 2016-05-23 | Lefkowitz Steven W (Director) | Sale | 15,126 | 3.00 | 45,378 |
| 2016-05-23 | Lefkowitz Steven W (Director) | Option Ex | 50,000 | .68 | 34,000 |
| 2016-05-20 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 10,000 | 2.89 | 28,860 |
| 2016-05-20 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 10,000 | .68 | 6,800 |
| 2016-05-20 | Lefkowitz Steven W (Director) | Sale | 14,874 | 2.86 | 42,584 |
| 2016-05-19 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 11,800 | 2.80 | 33,075 |
| 2016-05-18 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 500 | 3.21 | 1,606 |
| 2016-05-18 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 12,300 | .68 | 8,364 |
| 2016-05-16 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 20,000 | 2.79 | 55,839 |
| 2016-05-13 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 40,000 | 2.63 | 105,120 |
| 2016-05-13 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 60,000 | .68 | 40,800 |
| 2016-02-04 | Lefkowitz Steven W (Director) | Option Ex | 30,000 | .29 | 8,700 |
| 2015-09-22 | Dillione Janet (Director) | Buy | 15,000 | 2.66 | 39,900 |
| 2015-06-30 | Milby Randy (Chief Executive Officer) | Buy | 1,610 | 3.88 | 6,246 |
| 2015-06-23 | Markvicka Taunia (Director) | Buy | 4,000 | 4.81 | 19,240 |
| 2015-06-15 | Milby Randy (Chief Executive Officer) | Buy | 1,245 | 5.02 | 6,249 |
| 2015-06-04 | Duffy Matthew (Director) | Sale | 30,000 | 6.48 | 194,400 |
| 2015-06-02 | Duffy Matthew (Director) | Option Ex | 40,000 | .28 | 11,399 |
| 2015-06-01 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 30,000 | 6.37 | 191,040 |
| 2015-06-01 | Pfaffle Antony (Interim Chief Medical Officer) | Option Ex | 30,000 | .29 | 8,700 |
| 2015-06-01 | Lefkowitz Steven W (Director) | Sale | 29,072 | 6.66 | 193,503 |
| 2015-05-29 | Milby Randy (Chief Executive Officer) | Buy | 1,026 | 6.09 | 6,248 |
| 2015-05-28 | Lefkowitz Steven W (Director) | Sale | 10,000 | 6.16 | 61,600 |
| 2015-05-15 | Milby Randy (Chief Executive Officer) | Buy | 979 | 6.38 | 6,246 |
| 2015-05-14 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 12,003 | 6.49 | 77,875 |
| 2015-05-13 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 4,722 | 6.50 | 30,669 |
| 2015-04-15 | Milby Randy (Chief Executive Officer) | Buy | 730 | 8.55 | 6,241 |
| 2015-02-27 | Milby Randy (Chief Executive Officer) | Buy | 1,211 | 5.16 | 6,248 |
| 2015-02-13 | Milby Randy (Chief Executive Officer) | Buy | 1,911 | 3.27 | 6,248 |
| 2015-01-30 | Milby Randy (Chief Executive Officer) | Buy | 2,016 | 3.10 | 6,249 |
| 2014-12-31 | Milby Randy (Chief Executive Officer) | Buy | 3,272 | 1.91 | 6,249 |
| 2014-12-15 | Milby Randy (Chief Executive Officer) | Buy | 4,734 | 1.32 | 6,248 |
| 2014-11-28 | Milby Randy (Chief Executive Officer) | Buy | 4,464 | 1.40 | 6,249 |
| 2014-11-14 | Milby Randy (Chief Executive Officer) | Buy | 4,111 | 1.52 | 6,248 |
| 2014-11-14 | Tellez Cora M (Director) | Buy | 11,086 | 1.52 | 16,850 |
| 2014-10-31 | Milby Randy (Chief Executive Officer) | Buy | 3,434 | 1.82 | 6,249 |
| 2014-10-17 | Tellez Cora M (Director) | Buy | 2,100 | 1.55 | 3,252 |
| 2014-10-15 | Milby Randy (Chief Executive Officer) | Buy | 4,058 | 1.54 | 6,249 |
| 2014-09-30 | Milby Randy (Chief Executive Officer) | Buy | 3,324 | 1.88 | 6,249 |
| 2014-09-15 | Milby Randy (Chief Executive Officer) | Buy | 3,654 | 1.71 | 6,248 |
| 2014-08-29 | Milby Randy (Chief Executive Officer) | Buy | 3,125 | 2.00 | 6,250 |
| 2014-08-15 | Milby Randy (Chief Executive Officer) | Buy | 3,140 | 1.99 | 6,248 |
| 2014-07-31 | Milby Randy (Chief Executive Officer) | Buy | 6,250 | 2.00 | 12,500 |
| 2014-06-30 | Milby Randy (Chief Executive Officer) | Buy | 2,732 | 1.83 | 4,999 |
| 2013-12-16 | Lefkowitz Steven W (Interim Chief Financial Ofcr) | Buy | 7,500 | .74 | 5,550 |
| 2013-12-13 | Lefkowitz Steven W (Interim Chief Financial Ofcr) | Buy | 10,500 | .80 | 8,400 |
| 2013-09-24 | Pfaffle Antony (Interim Chief Medical Officer) | Sale | 125 | .92 | 115 |
| 2012-04-12 | Pharmabio Development Inc (10% Owner) | Sale | 11,000 | .45 | 4,950 |
| 2011-12-16 | Gelbfish Gary A. | Buy | 23,300 | .33 | 7,712 |
| 2011-12-16 | Lefkowitz Steven W | Buy | 15,000 | .31 | 4,650 |
| 2011-12-15 | Lefkowitz James | Buy | 1,200 | .31 | 372 |
| 2011-12-15 | Pfaffle Antony | Buy | 2,000 | .32 | 640 |
| 2011-12-14 | Lenz Brian (CFO, TREASURER & SECRETARY) | Buy | 14,000 | .34 | 4,760 |
| 2011-12-09 | Hofer Timothy M | Buy | 1,000 | .33 | 330 |
| 2010-11-26 | Houser Mark T. (Chief Medical Officer) | Buy | 5,000 | 1.30 | 6,490 |
| 2010-08-18 | Houghton John C. (President and CEO) | Buy | 1,000 | 1.62 | 1,623 |
| 2010-08-16 | Houser Mark T. (Chief Medical Officer) | Buy | 5,000 | 1.50 | 7,500 |
| 2010-08-16 | Lenz Brian (Chief Financial Officer) | Buy | 1,000 | 1.54 | 1,540 |
| 2010-03-30 | Houghton John C. (President and CEO) | Buy | 2,800 | .00 | 0 |
| 2010-03-30 | Ellison Russell H | Buy | 160,000 | .00 | 0 |
| 2010-03-30 | Lenz Brian (Chief Financial Officer) | Buy | 2,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRMD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cormedix Inc. (symbol CRMD, CIK number 1410098) see the Securities and Exchange Commission (SEC) website.